Japan vs Malta: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Japan
0.0%
in 2024
Malta
0.0%
in 2024
Japan rank
143rd
Malta rank
143rd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Japan
- Malta
How they compare
Japan currently reports 0.0% against 0.0% in Malta, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Malta ahead.
Japan ranks 143rd and Malta ranks 143rd of 215 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.0% | 0.0% | Japan |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Japan or Malta?
- Japan, at 0.0% against 0.0% in Malta as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Japan and Malta?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Malta?
- 10 years are reported by both, from 2015 to 2024.
- How do Japan and Malta rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Japan ranks 143rd and Malta ranks 143rd of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.